第3世代EGFRのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global 3rd Generation EGFR Market Insights, Forecast to 2028

• レポートコード：QY2207E10346 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、75ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の第3世代EGFRの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に第3世代EGFRの世界市場のxxx％を占める「モノクローナル抗体クラス」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「肺がん」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の第3世代EGFRの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの第3世代EGFR市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの第3世代EGFR市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 第3世代EGFRのグローバル主要メーカーには、Shanghai Allist Pharmaceuticals、Betta Pharmaceuticals、Nanjing Sanhome Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 第3世代EGFR市場は、種類と用途によって区分されます。世界の第3世代EGFR市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 モノクローナル抗体クラス、小分子チロシンキナーゼ阻害剤（TKI） 【用途別セグメント】 肺がん、肝臓がん、胃がん、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 第3世代EGFR製品概要 - 種類別市場（モノクローナル抗体クラス、小分子チロシンキナーゼ阻害剤（TKI）） - 用途別市場（肺がん、肝臓がん、胃がん、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の第3世代EGFR販売量予測2017-2028 - 世界の第3世代EGFR売上予測2017-2028 - 第3世代EGFRの地域別販売量 - 第3世代EGFRの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別第3世代EGFR販売量 - 主要メーカー別第3世代EGFR売上 - 主要メーカー別第3世代EGFR価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（モノクローナル抗体クラス、小分子チロシンキナーゼ阻害剤（TKI）） - 第3世代EGFRの種類別販売量 - 第3世代EGFRの種類別売上 - 第3世代EGFRの種類別価格 ・用途別市場規模（肺がん、肝臓がん、胃がん、その他） - 第3世代EGFRの用途別販売量 - 第3世代EGFRの用途別売上 - 第3世代EGFRの用途別価格 ・北米市場 - 北米の第3世代EGFR市場規模（種類別、用途別） - 主要国別の第3世代EGFR市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの第3世代EGFR市場規模（種類別、用途別） - 主要国別の第3世代EGFR市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の第3世代EGFR市場規模（種類別、用途別） - 主要国別の第3世代EGFR市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の第3世代EGFR市場規模（種類別、用途別） - 主要国別の第3世代EGFR市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの第3世代EGFR市場規模（種類別、用途別） - 主要国別の第3世代EGFR市場規模（トルコ、サウジアラビア） ・企業情報 Shanghai Allist Pharmaceuticals、Betta Pharmaceuticals、Nanjing Sanhome Pharmaceutical ・産業チェーン及び販売チャネル分析 - 第3世代EGFRの産業チェーン分析 - 第3世代EGFRの原材料 - 第3世代EGFRの生産プロセス - 第3世代EGFRの販売及びマーケティング - 第3世代EGFRの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 第3世代EGFRの産業動向 - 第3世代EGFRのマーケットドライバー - 第3世代EGFRの課題 - 第3世代EGFRの阻害要因 ・主な調査結果

Market Analysis and Insights: Global 3rd Generation EGFR Market
Due to the COVID-19 pandemic, the global 3rd Generation EGFR market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Monoclonal Antibody Class accounting for % of the 3rd Generation EGFR global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Lung Cancer segment is altered to an % CAGR throughout this forecast period.
China 3rd Generation EGFR market size is valued at US$ million in 2021, while the US and Europe 3rd Generation EGFR are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe 3rd Generation EGFR landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of 3rd Generation EGFR include Shanghai Allist Pharmaceuticals, Betta Pharmaceuticals and Nanjing Sanhome Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global 3rd Generation EGFR Scope and Segment
3rd Generation EGFR market is segmented by Type and by Application. Players, stakeholders, and other participants in the global 3rd Generation EGFR market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Monoclonal Antibody Class
Small Molecule Tyrosine Kinase Inhibitors (TKIs)
Segment by Application
Lung Cancer
Liver Cancer
Stomach Cancer
Other
By Company
Shanghai Allist Pharmaceuticals
Betta Pharmaceuticals
Nanjing Sanhome Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 3rd Generation EGFR Product Introduction
1.2 Market by Type
1.2.1 Global 3rd Generation EGFR Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibody Class
1.2.3 Small Molecule Tyrosine Kinase Inhibitors (TKIs)
1.3 Market by Application
1.3.1 Global 3rd Generation EGFR Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lung Cancer
1.3.3 Liver Cancer
1.3.4 Stomach Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global 3rd Generation EGFR Sales Estimates and Forecasts 2017-2028
2.2 Global 3rd Generation EGFR Revenue Estimates and Forecasts 2017-2028
2.3 Global 3rd Generation EGFR Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global 3rd Generation EGFR Sales by Region
2.4.1 Global 3rd Generation EGFR Sales by Region (2017-2022)
2.4.2 Global Sales 3rd Generation EGFR by Region (2023-2028)
2.5 Global 3rd Generation EGFR Revenue by Region
2.5.1 Global 3rd Generation EGFR Revenue by Region (2017-2022)
2.5.2 Global 3rd Generation EGFR Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global 3rd Generation EGFR Sales by Manufacturers
3.1.1 Global Top 3rd Generation EGFR Manufacturers by Sales (2017-2022)
3.1.2 Global 3rd Generation EGFR Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of 3rd Generation EGFR in 2021
3.2 Global 3rd Generation EGFR Revenue by Manufacturers
3.2.1 Global 3rd Generation EGFR Revenue by Manufacturers (2017-2022)
3.2.2 Global 3rd Generation EGFR Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by 3rd Generation EGFR Revenue in 2021
3.3 Global 3rd Generation EGFR Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global 3rd Generation EGFR Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global 3rd Generation EGFR Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global 3rd Generation EGFR Sales by Type
4.1.1 Global 3rd Generation EGFR Historical Sales by Type (2017-2022)
4.1.2 Global 3rd Generation EGFR Forecasted Sales by Type (2023-2028)
4.1.3 Global 3rd Generation EGFR Sales Market Share by Type (2017-2028)
4.2 Global 3rd Generation EGFR Revenue by Type
4.2.1 Global 3rd Generation EGFR Historical Revenue by Type (2017-2022)
4.2.2 Global 3rd Generation EGFR Forecasted Revenue by Type (2023-2028)
4.2.3 Global 3rd Generation EGFR Revenue Market Share by Type (2017-2028)
4.3 Global 3rd Generation EGFR Price by Type
4.3.1 Global 3rd Generation EGFR Price by Type (2017-2022)
4.3.2 Global 3rd Generation EGFR Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global 3rd Generation EGFR Sales by Application
5.1.1 Global 3rd Generation EGFR Historical Sales by Application (2017-2022)
5.1.2 Global 3rd Generation EGFR Forecasted Sales by Application (2023-2028)
5.1.3 Global 3rd Generation EGFR Sales Market Share by Application (2017-2028)
5.2 Global 3rd Generation EGFR Revenue by Application
5.2.1 Global 3rd Generation EGFR Historical Revenue by Application (2017-2022)
5.2.2 Global 3rd Generation EGFR Forecasted Revenue by Application (2023-2028)
5.2.3 Global 3rd Generation EGFR Revenue Market Share by Application (2017-2028)
5.3 Global 3rd Generation EGFR Price by Application
5.3.1 Global 3rd Generation EGFR Price by Application (2017-2022)
5.3.2 Global 3rd Generation EGFR Price Forecast by Application (2023-2028)
6 North America
6.1 North America 3rd Generation EGFR Market Size by Type
6.1.1 North America 3rd Generation EGFR Sales by Type (2017-2028)
6.1.2 North America 3rd Generation EGFR Revenue by Type (2017-2028)
6.2 North America 3rd Generation EGFR Market Size by Application
6.2.1 North America 3rd Generation EGFR Sales by Application (2017-2028)
6.2.2 North America 3rd Generation EGFR Revenue by Application (2017-2028)
6.3 North America 3rd Generation EGFR Market Size by Country
6.3.1 North America 3rd Generation EGFR Sales by Country (2017-2028)
6.3.2 North America 3rd Generation EGFR Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe 3rd Generation EGFR Market Size by Type
7.1.1 Europe 3rd Generation EGFR Sales by Type (2017-2028)
7.1.2 Europe 3rd Generation EGFR Revenue by Type (2017-2028)
7.2 Europe 3rd Generation EGFR Market Size by Application
7.2.1 Europe 3rd Generation EGFR Sales by Application (2017-2028)
7.2.2 Europe 3rd Generation EGFR Revenue by Application (2017-2028)
7.3 Europe 3rd Generation EGFR Market Size by Country
7.3.1 Europe 3rd Generation EGFR Sales by Country (2017-2028)
7.3.2 Europe 3rd Generation EGFR Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific 3rd Generation EGFR Market Size by Type
8.1.1 Asia Pacific 3rd Generation EGFR Sales by Type (2017-2028)
8.1.2 Asia Pacific 3rd Generation EGFR Revenue by Type (2017-2028)
8.2 Asia Pacific 3rd Generation EGFR Market Size by Application
8.2.1 Asia Pacific 3rd Generation EGFR Sales by Application (2017-2028)
8.2.2 Asia Pacific 3rd Generation EGFR Revenue by Application (2017-2028)
8.3 Asia Pacific 3rd Generation EGFR Market Size by Region
8.3.1 Asia Pacific 3rd Generation EGFR Sales by Region (2017-2028)
8.3.2 Asia Pacific 3rd Generation EGFR Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America 3rd Generation EGFR Market Size by Type
9.1.1 Latin America 3rd Generation EGFR Sales by Type (2017-2028)
9.1.2 Latin America 3rd Generation EGFR Revenue by Type (2017-2028)
9.2 Latin America 3rd Generation EGFR Market Size by Application
9.2.1 Latin America 3rd Generation EGFR Sales by Application (2017-2028)
9.2.2 Latin America 3rd Generation EGFR Revenue by Application (2017-2028)
9.3 Latin America 3rd Generation EGFR Market Size by Country
9.3.1 Latin America 3rd Generation EGFR Sales by Country (2017-2028)
9.3.2 Latin America 3rd Generation EGFR Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa 3rd Generation EGFR Market Size by Type
10.1.1 Middle East and Africa 3rd Generation EGFR Sales by Type (2017-2028)
10.1.2 Middle East and Africa 3rd Generation EGFR Revenue by Type (2017-2028)
10.2 Middle East and Africa 3rd Generation EGFR Market Size by Application
10.2.1 Middle East and Africa 3rd Generation EGFR Sales by Application (2017-2028)
10.2.2 Middle East and Africa 3rd Generation EGFR Revenue by Application (2017-2028)
10.3 Middle East and Africa 3rd Generation EGFR Market Size by Country
10.3.1 Middle East and Africa 3rd Generation EGFR Sales by Country (2017-2028)
10.3.2 Middle East and Africa 3rd Generation EGFR Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shanghai Allist Pharmaceuticals
11.1.1 Shanghai Allist Pharmaceuticals Corporation Information
11.1.2 Shanghai Allist Pharmaceuticals Overview
11.1.3 Shanghai Allist Pharmaceuticals 3rd Generation EGFR Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shanghai Allist Pharmaceuticals 3rd Generation EGFR Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shanghai Allist Pharmaceuticals Recent Developments
11.2 Betta Pharmaceuticals
11.2.1 Betta Pharmaceuticals Corporation Information
11.2.2 Betta Pharmaceuticals Overview
11.2.3 Betta Pharmaceuticals 3rd Generation EGFR Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Betta Pharmaceuticals 3rd Generation EGFR Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Betta Pharmaceuticals Recent Developments
11.3 Nanjing Sanhome Pharmaceutical
11.3.1 Nanjing Sanhome Pharmaceutical Corporation Information
11.3.2 Nanjing Sanhome Pharmaceutical Overview
11.3.3 Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nanjing Sanhome Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 3rd Generation EGFR Industry Chain Analysis
12.2 3rd Generation EGFR Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 3rd Generation EGFR Production Mode & Process
12.4 3rd Generation EGFR Sales and Marketing
12.4.1 3rd Generation EGFR Sales Channels
12.4.2 3rd Generation EGFR Distributors
12.5 3rd Generation EGFR Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 3rd Generation EGFR Industry Trends
13.2 3rd Generation EGFR Market Drivers
13.3 3rd Generation EGFR Market Challenges
13.4 3rd Generation EGFR Market Restraints
14 Key Findings in The Global 3rd Generation EGFR Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global 3rd Generation EGFR Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody Class
Table 3. Major Manufacturers of Small Molecule Tyrosine Kinase Inhibitors (TKIs)
Table 4. Global 3rd Generation EGFR Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global 3rd Generation EGFR Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global 3rd Generation EGFR Sales by Region (2017-2022) & (K Pcs)
Table 7. Global 3rd Generation EGFR Sales Market Share by Region (2017-2022)
Table 8. Global 3rd Generation EGFR Sales by Region (2023-2028) & (K Pcs)
Table 9. Global 3rd Generation EGFR Sales Market Share by Region (2023-2028)
Table 10. Global 3rd Generation EGFR Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global 3rd Generation EGFR Revenue Market Share by Region (2017-2022)
Table 12. Global 3rd Generation EGFR Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global 3rd Generation EGFR Revenue Market Share by Region (2023-2028)
Table 14. Global 3rd Generation EGFR Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global 3rd Generation EGFR Sales Share by Manufacturers (2017-2022)
Table 16. Global 3rd Generation EGFR Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global 3rd Generation EGFR Revenue Share by Manufacturers (2017-2022)
Table 18. 3rd Generation EGFR Price by Manufacturers (2017-2022) &(US$/Pcs)
Table 19. Global 3rd Generation EGFR Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global 3rd Generation EGFR by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3rd Generation EGFR as of 2021)
Table 21. 3rd Generation EGFR Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers 3rd Generation EGFR Product Offered
Table 23. Date of Manufacturers Enter into 3rd Generation EGFR Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global 3rd Generation EGFR Sales by Type (2017-2022) & (K Pcs)
Table 26. Global 3rd Generation EGFR Sales by Type (2023-2028) & (K Pcs)
Table 27. Global 3rd Generation EGFR Sales Share by Type (2017-2022)
Table 28. Global 3rd Generation EGFR Sales Share by Type (2023-2028)
Table 29. Global 3rd Generation EGFR Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global 3rd Generation EGFR Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global 3rd Generation EGFR Revenue Share by Type (2017-2022)
Table 32. Global 3rd Generation EGFR Revenue Share by Type (2023-2028)
Table 33. 3rd Generation EGFR Price by Type (2017-2022) & (US$/Pcs)
Table 34. Global 3rd Generation EGFR Price Forecast by Type (2023-2028) & (US$/Pcs)
Table 35. Global 3rd Generation EGFR Sales by Application (2017-2022) & (K Pcs)
Table 36. Global 3rd Generation EGFR Sales by Application (2023-2028) & (K Pcs)
Table 37. Global 3rd Generation EGFR Sales Share by Application (2017-2022)
Table 38. Global 3rd Generation EGFR Sales Share by Application (2023-2028)
Table 39. Global 3rd Generation EGFR Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global 3rd Generation EGFR Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global 3rd Generation EGFR Revenue Share by Application (2017-2022)
Table 42. Global 3rd Generation EGFR Revenue Share by Application (2023-2028)
Table 43. 3rd Generation EGFR Price by Application (2017-2022) & (US$/Pcs)
Table 44. Global 3rd Generation EGFR Price Forecast by Application (2023-2028) & (US$/Pcs)
Table 45. North America 3rd Generation EGFR Sales by Type (2017-2022) & (K Pcs)
Table 46. North America 3rd Generation EGFR Sales by Type (2023-2028) & (K Pcs)
Table 47. North America 3rd Generation EGFR Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America 3rd Generation EGFR Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America 3rd Generation EGFR Sales by Application (2017-2022) & (K Pcs)
Table 50. North America 3rd Generation EGFR Sales by Application (2023-2028) & (K Pcs)
Table 51. North America 3rd Generation EGFR Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America 3rd Generation EGFR Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America 3rd Generation EGFR Sales by Country (2017-2022) & (K Pcs)
Table 54. North America 3rd Generation EGFR Sales by Country (2023-2028) & (K Pcs)
Table 55. North America 3rd Generation EGFR Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America 3rd Generation EGFR Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe 3rd Generation EGFR Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe 3rd Generation EGFR Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe 3rd Generation EGFR Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe 3rd Generation EGFR Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe 3rd Generation EGFR Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe 3rd Generation EGFR Sales by Application (2023-2028) & (K Pcs)
Table 63. Europe 3rd Generation EGFR Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe 3rd Generation EGFR Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe 3rd Generation EGFR Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe 3rd Generation EGFR Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe 3rd Generation EGFR Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe 3rd Generation EGFR Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific 3rd Generation EGFR Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific 3rd Generation EGFR Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific 3rd Generation EGFR Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific 3rd Generation EGFR Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific 3rd Generation EGFR Sales by Application (2017-2022) & (K Pcs)
Table 74. Asia Pacific 3rd Generation EGFR Sales by Application (2023-2028) & (K Pcs)
Table 75. Asia Pacific 3rd Generation EGFR Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific 3rd Generation EGFR Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific 3rd Generation EGFR Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific 3rd Generation EGFR Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific 3rd Generation EGFR Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific 3rd Generation EGFR Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America 3rd Generation EGFR Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America 3rd Generation EGFR Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America 3rd Generation EGFR Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America 3rd Generation EGFR Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America 3rd Generation EGFR Sales by Application (2017-2022) & (K Pcs)
Table 86. Latin America 3rd Generation EGFR Sales by Application (2023-2028) & (K Pcs)
Table 87. Latin America 3rd Generation EGFR Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America 3rd Generation EGFR Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America 3rd Generation EGFR Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America 3rd Generation EGFR Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America 3rd Generation EGFR Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America 3rd Generation EGFR Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa 3rd Generation EGFR Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa 3rd Generation EGFR Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa 3rd Generation EGFR Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa 3rd Generation EGFR Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa 3rd Generation EGFR Sales by Application (2017-2022) & (K Pcs)
Table 98. Middle East and Africa 3rd Generation EGFR Sales by Application (2023-2028) & (K Pcs)
Table 99. Middle East and Africa 3rd Generation EGFR Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa 3rd Generation EGFR Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa 3rd Generation EGFR Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa 3rd Generation EGFR Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa 3rd Generation EGFR Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa 3rd Generation EGFR Revenue by Country (2023-2028) & (US$ Million)
Table 105. Shanghai Allist Pharmaceuticals Corporation Information
Table 106. Shanghai Allist Pharmaceuticals Description and Major Businesses
Table 107. Shanghai Allist Pharmaceuticals 3rd Generation EGFR Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 108. Shanghai Allist Pharmaceuticals 3rd Generation EGFR Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Shanghai Allist Pharmaceuticals Recent Developments
Table 110. Betta Pharmaceuticals Corporation Information
Table 111. Betta Pharmaceuticals Description and Major Businesses
Table 112. Betta Pharmaceuticals 3rd Generation EGFR Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 113. Betta Pharmaceuticals 3rd Generation EGFR Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Betta Pharmaceuticals Recent Developments
Table 115. Nanjing Sanhome Pharmaceutical Corporation Information
Table 116. Nanjing Sanhome Pharmaceutical Description and Major Businesses
Table 117. Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 118. Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Nanjing Sanhome Pharmaceutical Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. 3rd Generation EGFR Distributors List
Table 123. 3rd Generation EGFR Customers List
Table 124. 3rd Generation EGFR Market Trends
Table 125. 3rd Generation EGFR Market Drivers
Table 126. 3rd Generation EGFR Market Challenges
Table 127. 3rd Generation EGFR Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. 3rd Generation EGFR Product Picture
Figure 3. Global 3rd Generation EGFR Market Share by Type in 2021 & 2028
Figure 3. Monoclonal Antibody Class Product Picture
Figure 4. Small Molecule Tyrosine Kinase Inhibitors (TKIs) Product Picture
Figure 5. Global 3rd Generation EGFR Market Share by Application in 2021 & 2028
Figure 6. Lung Cancer
Figure 7. Liver Cancer
Figure 8. Stomach Cancer
Figure 9. Other
Figure 10. 3rd Generation EGFR Report Years Considered
Figure 11. Global 3rd Generation EGFR Sales 2017-2028 (K Pcs)
Figure 12. Global 3rd Generation EGFR Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global 3rd Generation EGFR Revenue 2017-2028 (US$ Million)
Figure 14. Global 3rd Generation EGFR Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global 3rd Generation EGFR Sales Market Share by Region (2017-2022)
Figure 16. Global 3rd Generation EGFR Sales Market Share by Region (2023-2028)
Figure 17. North America 3rd Generation EGFR Sales YoY (2017-2028) & (K Pcs)
Figure 18. North America 3rd Generation EGFR Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe 3rd Generation EGFR Sales YoY (2017-2028) & (K Pcs)
Figure 20. Europe 3rd Generation EGFR Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific 3rd Generation EGFR Sales YoY (2017-2028) & (K Pcs)
Figure 22. Asia-Pacific 3rd Generation EGFR Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America 3rd Generation EGFR Sales YoY (2017-2028) & (K Pcs)
Figure 24. Latin America 3rd Generation EGFR Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa 3rd Generation EGFR Sales YoY (2017-2028) & (K Pcs)
Figure 26. Middle East & Africa 3rd Generation EGFR Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The 3rd Generation EGFR Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of 3rd Generation EGFR in the World: Market Share by 3rd Generation EGFR Revenue in 2021
Figure 29. Global 3rd Generation EGFR Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global 3rd Generation EGFR Sales Market Share by Type (2017-2028)
Figure 31. Global 3rd Generation EGFR Revenue Market Share by Type (2017-2028)
Figure 32. Global 3rd Generation EGFR Sales Market Share by Application (2017-2028)
Figure 33. Global 3rd Generation EGFR Revenue Market Share by Application (2017-2028)
Figure 34. North America 3rd Generation EGFR Sales Market Share by Type (2017-2028)
Figure 35. North America 3rd Generation EGFR Revenue Market Share by Type (2017-2028)
Figure 36. North America 3rd Generation EGFR Sales Market Share by Application (2017-2028)
Figure 37. North America 3rd Generation EGFR Revenue Market Share by Application (2017-2028)
Figure 38. North America 3rd Generation EGFR Sales Share by Country (2017-2028)
Figure 39. North America 3rd Generation EGFR Revenue Share by Country (2017-2028)
Figure 40. United States 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 41. Canada 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 42. Europe 3rd Generation EGFR Sales Market Share by Type (2017-2028)
Figure 43. Europe 3rd Generation EGFR Revenue Market Share by Type (2017-2028)
Figure 44. Europe 3rd Generation EGFR Sales Market Share by Application (2017-2028)
Figure 45. Europe 3rd Generation EGFR Revenue Market Share by Application (2017-2028)
Figure 46. Europe 3rd Generation EGFR Sales Share by Country (2017-2028)
Figure 47. Europe 3rd Generation EGFR Revenue Share by Country (2017-2028)
Figure 48. Germany 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 49. France 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 51. Italy 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 52. Russia 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific 3rd Generation EGFR Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific 3rd Generation EGFR Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific 3rd Generation EGFR Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific 3rd Generation EGFR Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific 3rd Generation EGFR Sales Share by Region (2017-2028)
Figure 58. Asia Pacific 3rd Generation EGFR Revenue Share by Region (2017-2028)
Figure 59. China 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 60. Japan 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 62. India 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 63. Australia 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America 3rd Generation EGFR Sales Market Share by Type (2017-2028)
Figure 69. Latin America 3rd Generation EGFR Revenue Market Share by Type (2017-2028)
Figure 70. Latin America 3rd Generation EGFR Sales Market Share by Application (2017-2028)
Figure 71. Latin America 3rd Generation EGFR Revenue Market Share by Application (2017-2028)
Figure 72. Latin America 3rd Generation EGFR Sales Share by Country (2017-2028)
Figure 73. Latin America 3rd Generation EGFR Revenue Share by Country (2017-2028)
Figure 74. Mexico 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa 3rd Generation EGFR Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa 3rd Generation EGFR Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa 3rd Generation EGFR Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa 3rd Generation EGFR Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa 3rd Generation EGFR Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa 3rd Generation EGFR Revenue Share by Country (2017-2028)
Figure 84. Turkey 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 86. UAE 3rd Generation EGFR Revenue (2017-2028) & (US$ Million)
Figure 87. 3rd Generation EGFR Value Chain
Figure 88. 3rd Generation EGFR Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

---